Active Ingredient: Betaxolol
Betaxolol is indicated for the reduction of elevated intraocular pressure in patients with ocular hypertension and chronic open angle glaucoma.
For this indication, competent medicine agencies globally authorize below treatments:
Ophthalmic
2 {drops}
1 {drops} 2 time(s) per day every day
The recommended dose is one drop in the affected eye(s) twice daily. In some patients, the intraocular pressure lowering responses to betaxolol may require a few weeks to stabilise. Careful monitoring of glaucoma patients is advised. If the intraocular pressure of the patient is not adequately controlled on this regimen, concomitant therapy with pilocarpine and other miotics and/or adrenaline (epinephrine) and/or carbonic anhydrase inhibitors can be instituted.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
